Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Maxgalin ER-150 Pregabalin Extended Release Tablet:
Maxgalin ER-150 is an extended-release formulation of Pregabalin, designed to provide consistent therapeutic effects for managing neuropathic pain, epilepsy, and anxiety disorders. This reliable treatment option supports patients in achieving better health outcomes.
Uses of Maxgalin ER-150 Pregabalin Extended Release Tablet:
Maxgalin ER-150 is indicated for:
Managing neuropathic pain associated with diabetic neuropathy or postherpetic neuralgia
Treating partial-onset seizures in adults with epilepsy
Alleviating symptoms of generalized anxiety disorder
Benefits of Maxgalin ER-150 Pregabalin Extended Release Tablet:
Extended-release formulation for once-daily dosing
Effective relief from neuropathic pain and anxiety symptoms
Reduces seizure frequency in epilepsy patients
Enhances overall quality of life by managing chronic pain and anxiety
Mechanism of Action of Maxgalin ER-150 Pregabalin Extended Release Tablet:
Pregabalin, the active ingredient in Maxgalin ER-150, works by inhibiting excitatory neurotransmitter release in the central nervous system. This action reduces pain transmission in neuropathic conditions, decreases seizure activity, and alleviates anxiety symptoms, providing comprehensive management for patients with diverse needs.